Compounds for immunotherapy of breast cancer and methods for their use
    93.
    发明授权
    Compounds for immunotherapy of breast cancer and methods for their use 失效
    用于乳腺癌免疫治疗的化合物及其使用方法

    公开(公告)号:US06379951B1

    公开(公告)日:2002-04-30

    申请号:US09118627

    申请日:1998-07-17

    IPC分类号: C07H2104

    CPC分类号: C07K14/82 A61K38/00 A61K39/00

    摘要: Compounds and methods for treating breast cancer are provided. The inventive compounds include polypeptides containing at least a portion of a breast tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of breast cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.

    摘要翻译: 提供了治疗乳腺癌的化合物和方法。 本发明化合物包括含有至少一部分乳腺肿瘤蛋白质的多肽。 还提供了包含此类多肽的乳腺癌免疫治疗用疫苗和药物组合物,或编码此类多肽的DNA分子,以及用于制备本发明多肽的DNA分子。

    Compositions and methods for the prevention and treatment of M. tuberculosis infection
    94.
    发明授权
    Compositions and methods for the prevention and treatment of M. tuberculosis infection 失效
    预防和治疗结核分枝杆菌感染的组合物和方法

    公开(公告)号:US06350456B1

    公开(公告)日:2002-02-26

    申请号:US09056556

    申请日:1998-04-07

    IPC分类号: A61K304

    摘要: Compositions and methods for treatment and vaccination against tuberculosis are disclosed. In one aspect the compositions provided include at least two polypeptides that contain an immunogenic portion of a M. tuberculosis antigen or at least two DNA molecules encoding such polypeptides. In a second aspect, the compositions provided include a fusion protein comprising at least two polypeptides that contain an immunogenic portion of a M. tuberculosis antigen. Such compositions may be formulated into vaccines and/or pharmaceutical compositions for immunization against M. tuberculosis infection, or may be used for the diagnosis of tuberculosis.

    摘要翻译: 公开了治疗和接种针对结核病的组合物和方法。 在一个方面,所提供的组合物包括至少两种含有结核分枝杆菌抗原的免疫原性部分或至少两种编码这种多肽的DNA分子的多肽。 在第二方面,提供的组合物包括包含至少两种含有结核分枝杆菌抗原的免疫原性部分的多肽的融合蛋白。 这样的组合物可以配制成针对结核分枝杆菌感染免疫的疫苗和/或药物组合物,或可用于诊断结核病。

    Compounds and methods for diagnosis of lung cancer
    96.
    发明授权
    Compounds and methods for diagnosis of lung cancer 失效
    化合物和肺癌诊断方法

    公开(公告)号:US06210883B1

    公开(公告)日:2001-04-03

    申请号:US09040984

    申请日:1998-03-18

    IPC分类号: C12Q168

    摘要: Compounds and methods for treating lung cancer are provided. The inventive compounds include polypeptides containing at least a portion of a lung tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of lung cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.

    摘要翻译: 提供了治疗肺癌的化合物和方法。 本发明化合物包括含有至少一部分肺肿瘤蛋白的多肽。 还提供包含这种多肽的肺癌免疫治疗用疫苗和药物组合物,或编码这些多肽的DNA分子,以及用于制备本发明多肽的DNA分子。

    Methods for enhancement of protective immune responses
    98.
    发明授权
    Methods for enhancement of protective immune responses 失效
    增强保护性免疫反应的方法

    公开(公告)号:US5876735A

    公开(公告)日:1999-03-02

    申请号:US607509

    申请日:1996-02-23

    申请人: Steven G. Reed

    发明人: Steven G. Reed

    摘要: Methods for eliciting or enhancing immune responses to antigens, including tumor antigens, are provided. The methods employ polypeptides or nucleic acid compositions that contain at least a biologically active portion of a Leishmania braziliensis or Leishmania major homologue of the eukaryotic initiation factor 4A, or a variant thereof. Such polypeptides and compositions are useful for enhancing or eliciting a patient's cellular and/or humoral immune response, for instance within methods for treating tumors.

    摘要翻译: 提供了引发或增强对抗原的免疫应答的方法,包括肿瘤抗原。 该方法使用含有真菌起始因子4A的利什曼原虫或利什曼原虫重要同源物的至少生物活性部分或其变体的多肽或核酸组合物。 这样的多肽和组合物可用于增强或引发患者的细胞和/或体液免疫应答,例如用于治疗肿瘤的方法。

    230Kd antigen present in Leishmania species
    99.
    发明授权
    230Kd antigen present in Leishmania species 失效
    利什曼原虫存在230Kd抗原

    公开(公告)号:US5719263A

    公开(公告)日:1998-02-17

    申请号:US282845

    申请日:1994-07-28

    申请人: Steven G. Reed

    发明人: Steven G. Reed

    摘要: There is disclosed an isolated 230 Kd antigen which is present in Leishmania chagasi and Leishmania donovani, and an isolated polypeptide comprising one or a plurality of K39 repeat antigens. Also disclosed are DNAs encoding the 230 Kd antigen and the K39 repeat antigen, and vaccine compositions comprising the antigens.

    摘要翻译: 公开了一种存在于利什曼原虫和利什曼原虫的分离的230Kd抗原,以及包含一种或多种K39重复抗原的分离的多肽。 还公开了编码230Kd抗原和K39重复抗原的DNA和包含抗原的疫苗组合物。

    Peptide for detecting antibodies to a 260 kD T. cruzi antigen
    100.
    发明授权
    Peptide for detecting antibodies to a 260 kD T. cruzi antigen 失效
    用于检测260kD克氏锥虫抗原的抗体的肽

    公开(公告)号:US5413912A

    公开(公告)日:1995-05-09

    申请号:US169563

    申请日:1993-12-17

    申请人: Steven G. Reed

    发明人: Steven G. Reed

    摘要: There is disclosed an antigenic peptide that comprises at least 15 amino acids having the sequence Ala Glu Pro Lys X Ala Glu Pro Lys X Ala Glu Pro Lys X, wherein X is Pro or Ser. This peptide is useful in an ELISA assay to detect antibodies specific to T. cruzi infection and Chagas disease. This peptide is further useful in a vaccine composition for immunizing an individual to prevent Chagas disease upon exposure to T. cruzi.

    摘要翻译: 公开了包含至少15个具有序列Ala Glu Pro Lys X Ala Glu Pro Lys X Ala Glu Pro Lys X的氨基酸的抗原肽,其中X是Pro或Ser。 该肽可用于检测针对克氏锥虫感染和恰加斯病特异性的抗体的ELISA测定。 该肽还可用于疫苗组合物中,用于免疫个体以在暴露于克氏锥虫后防止恰加斯病。